Health Technology Assessments (HTA) demand more than robust evidence and Vista Health can support organisations in delivering impactful submissions through strategic alignment and expert guidance.
HTA submission is not an optional activity
Bodies such as NICE, SMC and NCPE hold the purse strings for new medicines. Success at HTA is the difference between being denied access and accelerated commercial return.
HTA requirements can appear complex and daunting. But these processes follow rules. An experienced partner can help you understand the key issues and focus on activities that deliver impactful benefits.
Why come to Vista Health for HTA submission support?
- Extensive experience in UK HTA submissions
- Strategic advice and evidence interrogation
- HTA & HEOR subject matter expertise
- Experienced response to HTA challenges
- Streamlined approach to submission delivery
Advise on post-submission activities
Vista Health have the experience to support you from initial concept to committee interaction.
Create the HTA strategy
Anticipate and manage challenges
Develop a focused and 
professional submission
Fine-tune the submission
Respond to agency feedback
Advise on post-submission decision
Where to begin?
The first step toward a successful submission is an assessment of readiness. Â Do you have the evidence you need to engage with HTA?
1. Define the decision problem
- Establish a clear place in therapy
- Demonstrate unmet need
- Identify an appropriate comparator
2. Show effectiveness and safety
- Comparative effectiveness
- Comparative safety
3. Show economic value
- Cost-effectiveness acceptable at target price
- Acceptable uncertainty around cost-effectiveness
Vista Health can help assess readiness, identify gaps and prioritise actions.
Vista Health can help assess readiness, identify gaps and prioritise actions.
